Profiel
Shobhit Dhawan is a Member-Supervisory Board at Immagene BV.
Previously, he worked as an Investment Manager at AMC Ventures Holding BV from 2015 to 2019.
Actieve functies van Shobhit Dhawan
| Bedrijven | Functie | Begin |
|---|---|---|
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Shobhit Dhawan
| Bedrijven | Functie | Einde |
|---|---|---|
AMC Ventures Holding BV
 AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Private Equity Investor | 01-04-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
AMC Ventures Holding BV
AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Finance |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
